Neurocrine Biosciences In... (NBIX)
NASDAQ: NBIX
· Real-Time Price · USD
144.13
3.73 (2.66%)
At close: Sep 05, 2025, 3:25 PM
Neurocrine Biosciences Revenue
Neurocrine Biosciences reported an annual revenue of $2.36B, reflecting a 24.81% growth. For the quarter ending June 30, 2025, Neurocrine Biosciences generated $687.5M in revenue.
Revenue (ttm)
2.36B
Revenue Growth
24.81%
Price / Sales Ratio
5.82
Revenue / Employee
1.31M
Employees
1,800
Market Cap
14.3B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 2.36B | +24.81% |
| Dec 31, 2023 | 1.89B | +26.76% |
| Dec 31, 2022 | 1.49B | +31.34% |
| Dec 31, 2021 | 1.13B | +8.38% |
| Dec 31, 2020 | 1.05B | +32.71% |
| Dec 31, 2019 | 788.1M | +74.67% |
| Dec 31, 2018 | 451.2M | +179.16% |
| Dec 31, 2017 | 161.63M | +977.51% |
| Dec 31, 2016 | 15M | -24.12% |
| Dec 31, 2015 | 19.77M | +Infinity% |
| Dec 31, 2014 | 0 | -100.00% |
| Dec 31, 2013 | 2.92M | -94.51% |
| Dec 31, 2012 | 53.14M | -31.36% |
| Dec 31, 2011 | 77.41M | +131.08% |
| Dec 31, 2010 | 33.5M | +1034.47% |
| Dec 31, 2009 | 2.95M | -25.71% |
| Dec 31, 2008 | 3.98M | +224.75% |
| Dec 31, 2007 | 1.22M | -96.88% |
| Dec 31, 2006 | 39.23M | -68.33% |
| Dec 31, 2005 | 123.89M | +45.45% |
| Dec 31, 2004 | 85.18M | -38.76% |
| Dec 31, 2003 | 139.08M | +670.73% |
| Dec 31, 2002 | 18.05M | -56.25% |
| Dec 31, 2001 | 41.24M | +182.71% |
| Dec 31, 2000 | 14.59M | -13.17% |
| Dec 31, 1999 | 16.8M | +5.00% |
| Dec 31, 1998 | 16M | -38.70% |
| Dec 31, 1997 | 26.1M | +35.94% |
| Dec 31, 1996 | 19.2M | n/a |